EyeGate ekes out a tiny IPO to fund its R&D efforts

Damian Garde

Massachusetts' Pharmaceuticals picked up $ 10 million in an IPO do-over, raising cash to support its sole clinical candidate.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS